Axiron is a prescription medication that treats male testosterone deficiency, and it may become the first-ever underarm treatment approved by the FDA. According to an article posted on TradingMarkets.com, Axiron can successfully boost a man’s sexual drive.
Sometimes, men with testosterone deficiency experience a reduction in sexual drive, but with Axiron, this effect is reversed in more than 80 percent of men who take it. This is great news for men with libido problems that stem from testosterone deficiency, especially because Axiron is so easy to apply. It can be used right alongside normal deodorants and antiperspirants.
It is important to note that Axiron is different from drugs like Viagra and Cialis, which treat erectile dysfunction only. These drugs don’t actually affect testosterone levels or increase sexual drive; they simply target the immediate cause of loss of erections – a lack of proper blood flow. Contrastingly, Axiron treats a hormone deficiency, which means it treats male libido problems at their root cause.
Best Course of Action: Talk to Your Doctor
Men who are experiencing sexual problems like lack of sex drive, or erection issues facts, should talk to their doctors. A physician may find that one of these two types of products can help. It’s possible that a doctor may prescribe both types of medications for men who have both hormonal issues and blood flow problems. In some cases, erection difficulties can be a direct result of a testosterone deficiency, which means that Axiron alone may be enough to fix the problems.
According to the Trading Markets article, Eli Lilly will be marketing Axiron, making the pharmaceutical manufacturer a powerful player in the field of male sexual health drugs. Lilly already owns the patent for Cialis, the second-most-popular erectile dysfunction drug behind Viagra.
Axiron May Help Alleviate More Than One Symptom
The best thing about the upcoming appearance of Axiron is that testosterone deficiency is not just a sexual problem. Men who experience testosterone deficiency – usually after their early 50s – often also experience fatigue, muscle loss, depression, and other symptoms.
If Axiron is as effective in treating testosterone deficiency as the Phase III trials seem to indicate, it could provide a major breakthrough in relieving this condition. Although Axiron may not be available until 2011 according to DataMonitor, it will be well worth the wait for many men.
We specialize in providing our over 1,000,000 customers with relevant product and condition information created by our professional editorial staff which includes our team of medical writers, medical practitioners, and health educators. eDrugStore.com Staff on Facebook